Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/OFSA3 stock hub

BVMF/OFSA3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/OFSA3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/OFSA3

In the news

Latest news · BVMF/OFSA3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E7.5

P25 n/aP50 n/aP75 n/a

ROE33.3

P25 n/aP50 n/aP75 n/a

ROIC26.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/OFSA3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

BRL

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	1,086
Employees Change	34%
Employees Change Percent	3.23
Enterprise value	BRL 1.9B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	BROFSAACNOR7
Last refreshed	2026-05-10
Market cap	BRL 1.8B
Price	BRL 33.54
Price currency	BRL
Rev Per Employee	1,184,065.38x
Sector	Healthcare
Sic	2834
Symbol	bvmf/OFSA3
Website	https://www.ourofinosaudeanimal.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	13.4%
EV Earnings	7.98x
EV/EBIT	7.2x
EV/EBITDA	6.51x
EV/FCF	12.79x
EV/Sales	1.5x
FCF yield	8.36%
P/B ratio	2.21x
P/E ratio	7.46x
P/S ratio	1.4x
PE Ratio10 Y	35.45x
PE Ratio3 Y	18.08x
PE Ratio5 Y	15.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.83%
EBITDA Margin	22.5%
FCF margin	11.73%
Gross margin	52.58%
Gross Profit	BRL 676.1M
Gross Profit Growth	29.04%
Gross Profit Growth Q	46.91%
Gross Profit Growth3 Y	10.19%
Gross Profit Growth5 Y	10.74%
Net Income	BRL 241.6M
Net Income Growth	95.6%
Net Income Growth Q	942.36%
Net Income Growth3 Y	29.5%
Net Income Growth5 Y	18.97%
Pretax Margin	19.28%
Profit Margin	18.79%
Profit Per Employee	BRL 222,486
ROA	11.55
Roa5y	8.07
ROCE	20.38
ROE	33.28
Roe5y	15.62
ROIC	26.22
Roic5y	12.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.09%
Cagr1y	54.88%
Cagr3y	19.42%
Cagr5y	6.27%
Div CAGR10	15.03%
Div CAGR3	26.61%
Div CAGR5	17.21%
EPS Growth	95.6
EPS Growth Q	942.4
EPS Growth3 Y	29.5
EPS Growth5 Y	19.05
FCF Growth	230.75%
FCF Growth Q	152.13%
FCF Growth3 Y	7.03%
FCF Growth5 Y	16.22%
OCF Growth	176.78%
OCF Growth Q	134.54%
OCF Growth10 Y	26.23%
OCF Growth3 Y	2.32%
OCF Growth5 Y	14.02%
Revenue Growth	24.13x
Revenue Growth Q	32.13x
Revenue Growth3 Y	8.53x
Revenue Growth5 Y	10.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.89
Assets	BRL 1.6B
Cash	BRL 401.1M
Current Assets	BRL 1.1B
Current Liabilities	BRL 316.9M
Debt	BRL 526M
Debt EBITDA	BRL 1.78
Debt Equity	BRL 0.64
Debt FCF	BRL 3.49
Equity	BRL 816.5M
Interest Coverage	7.39
Liabilities	BRL 814.3M
Long Term Assets	BRL 533.1M
Long Term Liabilities	BRL 497.4M
Net Cash	BRL -124.9M
Net Cash By Market Cap	BRL -6.93
Net Debt EBITDA	BRL 0.43
Net Debt Equity	BRL 0.15
Net Debt FCF	BRL 0.83
Tangible Book Value	BRL 711.9M
Tangible Book Value Per Share	BRL 13.24
WACC	6.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.46
Inventory Turnover	1.78
Net Working Capital	BRL 445.4M
Quick ratio	2.31
Working Capital	BRL 780.8M
Working Capital Turnover	BRL 2.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%
Dividend Growth	-56.4%
Dividend Growth Years	2%
Dividend per share	BRL 1.29
Dividend Years	12
Dividend Yield	3.85%
Ex Div Date	2026-04-17
Last Dividend	BRL 0.36
Payout Frequency	Semi-Annual
Payout Ratio	28.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	0.88%
1Y total return	54.83%
200-day SMA	24.23
3Y total return	70.34%
50-day SMA	28.49
50-day SMA vs 200-day SMA	50over200
5Y total return	35.5%
All Time High	46.04
All Time High Change	-27.15%
All Time High Date	2016-05-06
All Time Low	14.99
All Time Low Change	123.75%
All Time Low Date	2020-03-19
ATR	1.17
Beta	0.32
Beta1y	0.18
Beta2y	0.19
Ch YTD	45.83
High	34.69
High52	34.69
High52 Date	2026-05-08
High52ch	-3.32%
Low	33.5
Low52	20.9
Low52 Date	2025-10-21
Low52ch	60.48%
Ma50ch	17.71%
Price vs 200-day SMA	38.44%
RSI	68.5
RSI Monthly	70.72
RSI Weekly	83.28
Sharpe ratio	1.44x
Sortino ratio	2.6
Total Return	3.84%
Tr YTD	47.56
Tr1m	23.59%
Tr1w	9.43%
Tr3m	43.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 267.8M
Operating Income Growth	51.93
Operating Income Growth Q	293.9
Operating Income Growth3 Y	22.39
Operating Income Growth5 Y	13.73
Operating margin	20.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,284,666%
Net Borrowing	149,403,000
Shares Insiders	56.92%
Shares Institutions	2.42%
Shares Out	53,767,606
Shares Qo Q	-0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 144.3M
Average Volume	18,625x
Bv Per Share	15.19
CAPEX	BRL -26.7M
Ch10y	-27.07
Ch1m	22.14
Ch1w	9.43
Ch1y	46.91
Ch3m	42.12
Ch3y	34.16
Ch5y	1.64
Ch6m	41.52
Change	0.09%
Change From Open	-1.58
Close	33.51
Days Gap	1.7
Depreciation Amortization	21,507,000
Dollar Volume	301,860
Earnings Date	2026-05-07
EBIT	BRL 267.8M
EBITDA	BRL 289.3M
EPS	BRL 4.49
F Score	6
FCF	BRL 150.8M
FCF EV Yield	7.82x
FCF Per Share	BRL 2.8
Financing CF	111,250,000
Fiscal Year End	December
Founded	1,987
Graham Number	39.18365
Graham Upside	16.83
Income Tax	BRL 6.3M
Investing CF	-35,563,000
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	BRL 85.26
Lynch Upside	154.2
Ma150	24.95
Ma150ch	34.46%
Ma20	31.33
Ma20ch	7.06%
Net CF	252,601,000
Next Earnings Date	2026-08-06
Open	34.08
P FCF Ratio	11.96
P OCF Ratio	10.16
Payment Date	2026-04-30
Position In Range	3.36
Ppne	340,285,000
Price Date	2026-05-08
Price EBITDA	BRL 6.23
Ptbv Ratio	2.53
Relative Volume	0.48x
Revenue	1,285,895,000x
SBC By Revenue	0.51x
Share Based Comp	6,494,000
Tax By Revenue	0.49x
Tax Rate	2.54%
Tr6m	49.15%
Volume	9,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/OFSA3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.8%

$1.29 annual per share

Payout ratio

+28.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+17.2%

2 consecutive years of growth

Total shareholder yield

+3.8%

Next ex-dividend date: 2026-04-17

Performance

BVMF/OFSA3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/OFSA3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.4%

Share of float held by funds and institutions

Insider ownership

+56.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

BVMF/OFSA3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.5

Neutral momentum band

Price vs 200-day MA

+38.4%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/OFSA3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/OFSA3 stock rating?

bvmf/OFSA3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/OFSA3 analysis?

The full report lives at /stocks/bvmf/OFSA3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/OFSA3?

The latest report frames bvmf/OFSA3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/OFSA3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.